London · Delayed Price · Currency is GBP · Price in GBX Hemogenyx Pharmaceuticals Statistics
Total Valuation
LON:HEMO has a market cap or net worth of GBP 48.28 million. The enterprise value is 45.50 million.
| Market Cap | 48.28M |
| Enterprise Value | 45.50M |
Important Dates
The next estimated earnings date is Tuesday, December 29, 2026.
| Earnings Date | Dec 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LON:HEMO has 6.80 million shares outstanding. The number of shares has increased by 66.78% in one year.
| Current Share Class | 6.80M |
| Shares Outstanding | 6.80M |
| Shares Change (YoY) | +66.78% |
| Shares Change (QoQ) | +20.46% |
| Owned by Insiders (%) | 18.79% |
| Owned by Institutions (%) | 49.13% |
| Float | 5.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.30 |
| P/TBV Ratio | 11.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.43.
| Current Ratio | 4.04 |
| Quick Ratio | 4.04 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -57.13 |
Financial Efficiency
Return on equity (ROE) is -607.36% and return on invested capital (ROIC) is -187.95%.
| Return on Equity (ROE) | -607.36% |
| Return on Assets (ROA) | -146.71% |
| Return on Invested Capital (ROIC) | -187.95% |
| Return on Capital Employed (ROCE) | -206.80% |
| Weighted Average Cost of Capital (WACC) | 12.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -706,914 |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.68% in the last 52 weeks. The beta is 1.52, so LON:HEMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -31.68% |
| 50-Day Moving Average | 568.34 |
| 200-Day Moving Average | 751.94 |
| Relative Strength Index (RSI) | 59.86 |
| Average Volume (20 Days) | 26,872 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.71M |
| Pretax Income | -11.32M |
| Net Income | -11.31M |
| EBITDA | -11.58M |
| EBIT | -11.71M |
| Earnings Per Share (EPS) | -1.92 |
Balance Sheet
The company has 4.58 million in cash and 1.85 million in debt, with a net cash position of 2.73 million or 0.40 per share.
| Cash & Cash Equivalents | 4.58M |
| Total Debt | 1.85M |
| Net Cash | 2.73M |
| Net Cash Per Share | 0.40 |
| Equity (Book Value) | 4.27M |
| Book Value Per Share | 0.64 |
| Working Capital | 3.69M |
Cash Flow
| Operating Cash Flow | -1.61M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 128,473 |
| Net Borrowing | -606,237 |
| Free Cash Flow | -1.61M |
| FCF Per Share | -0.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:HEMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -66.78% |
| Shareholder Yield | -66.78% |
| Earnings Yield | -23.43% |
| FCF Yield | -3.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2024. It was a reverse split with a ratio of 0.0025.
| Last Split Date | Dec 13, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |